A Prospective, Multicentre, Randomized, Double-Blind, Placebo-Controlled, Large Simple Trial Evaluating the Use of BE1116 (4-Factor Prothrombin Complex Concentrate [Kcentra® / Beriplex® ]) to Improve Survival in Patients with Traumatic Injury and Acute Major Bleeding (NCT05568888)
CSL TAP
This trial is No longer recruiting
Registration number NCT05568888
Program & service
This trial is being run with the Surgery service, and as part of the Trauma program.
Trial phase
Phase 3
Trial participation type
This trial has been designed for the Clinical Research of a Drug.
Principal investigator
Professor Mark Fitzgerald
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTRIf you would like further details or have any questions about this clinical trial, we encourage you to get in touch with us and a member of our team will be happy to provide you with more information.